Abstract
A major advance over the past decade in the nosology of CNS inflammatory demyelinating diseases has been the distinction between classic MS (CMS) and neuromyelitis optica (NMO). Japanese investigators were first to recognize the optic-spinal form of MS (OSMS) in which, like NMO, clinical attacks of transverse myelitis and optic neuritis predominate. However, despite diagnostic advances that have facilitated the distinction between CMS and NMO, the relationship of Asian OSMS to MS and NMO as diagnosed in Western countries is still controversial. In both OSMS and NMO, the occurrence of aquaporin-4 autoantibodies and longitudinally extensive spinal cord lesions and less common but highly specific symptoms such as intractable vomiting and hiccough in both OSMS and NMO suggest that they are identical.1,–,3 However, some Japanese and Asian investigators argue that no characteristic is specific and that OSMS and classic MS represent a continuum.4,5 Another source of confusion is the changing definition of the NMO clinical phenotype based on a new biomarker, aquaporin-4 autoantibodies. It is now apparent that brain MRI lesions, once a key exclusion for NMO, occur in most cases, sometimes with patterns specific to NMO.6,7 Japanese investigators do not diagnose OSMS in patients with brain lesions. This issue is more than semantic as standard immunomodulatory MS therapies …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.